Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DermAtOmics: Cyclosporin in Atopic Dermatitis
NCT05692843Phase 4Unknown
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Oct 2022
- Primary completion
- Nov 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine in atopic dermatitis (AD), sponsored by Hospital La Paz Institute for Health Research. Status: unknown.
02
Drugs
cyclosporine
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05692843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05692843.